SCHEMBL26260667

SCHEMBL26260667

FC(F)(F)Oc1ccccc1Nc1ccc2[nH]c(CSc3ccnc(C(F)(F)F)c3)nc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP1 P22413 3/20 0.39
▸ ABCB1 P08183 3/20 0.39
▸ PDE10A Q9Y233 2/20 0.38
▸ AURKA O14965 1/20 0.37
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ TAS2R14 Q9NYV8 1/20 0.36
▸ PARP14 Q460N5 1/20 0.35
▸ C1R P00736 1/20 0.35
▸ SYK P43405 1/20 0.35
▸ POLB P06746 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260655 0.92 PARP14 (0.43) ENPP1ABCB1PDE10ANPC1RAB9A
SCHEMBL25436191 0.91 SMN1; SMN2 (0.42) ABCB1PDE10AAURKANPC1RAB9A
SCHEMBL23618319 0.88 ABCB1 (0.42) ENPP1ABCB1PDE10ANPC1RAB9A
SCHEMBL23618304 0.88 NPC1 (0.40) ABCB1PDE10ANPC1RAB9ASMN1; SMN2
SCHEMBL26261593 0.88 NPC1 (0.38) ABCB1PDE10ANPC1RAB9ASMN1; SMN2
SCHEMBL26260644 0.88 NPC1 (0.40) ABCB1PDE10AAURKANPC1RAB9A
SCHEMBL26260672 0.87 ABCB1 (0.41) ENPP1ABCB1PDE10ANPC1RAB9A
SCHEMBL30041184 0.87 ABCB1 (0.41) ENPP1ABCB1PDE10ANPC1RAB9A
SCHEMBL23618336 0.86 NPC1 (0.44) ABCB1PDE10ANPC1RAB9ASMN1; SMN2
SCHEMBL30040899 0.86 PDE10A (0.37) ABCB1PDE10ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286942-A1 NEW PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2023-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286942-A1 NEW PqsR INVERSE AGONISTS QRFPR, P2RY11, GPR55 ENPP1 1701/4885ABCB1 1506/4885PDE10A 356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback